Top compounds associated with response to HILPDA


Feature Type Standardized
Nominal ANOVA
mRNA bendamustine CTRPv2 pan-cancer AAC 0.11 0.003
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA BMS-345541 CTRPv2 pan-cancer AAC 0.11 0.004
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.11 0.004
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA L-685458 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.11 0.005
mRNA thapsigargin gCSI pan-cancer AAC -0.16 0.005
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.1 0.005
Download CSV